CALRETICULIN MODULATES THE IN-VITRO DNA-BINDING BUT NOT THE IN-VIVO TRANSCRIPTIONAL ACTIVATION BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR RETINOID-X RECEPTOR HETERODIMERS
Cj. Winrow et al., CALRETICULIN MODULATES THE IN-VITRO DNA-BINDING BUT NOT THE IN-VIVO TRANSCRIPTIONAL ACTIVATION BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR RETINOID-X RECEPTOR HETERODIMERS, Molecular and cellular endocrinology, 111(2), 1995, pp. 175-179
Calreticulin is a ubiquitous calcium binding/storage protein found pri
marily in the endoplasmic reticulum. Calreticulin has been shown to in
hibit DNA binding and transcriptional activation by glucocorticoid and
androgen hormone receptors by binding to the conserved sequence KXFF(
K/R)R, present in the DNA-binding domains of all known members of the
steroid/nuclear hormone receptor superfamily. To determine whether cal
reticulin might be a general regulator of hormone-responsive pathways,
we examined its effect on DNA binding in vitro and transcriptional ac
tivation in vivo by heterodimers of the peroxisome proliferator-activa
ted receptor (PPAR) and the 9-cis retinoic acid receptor (RXR alpha).
We show here that purified calreticulin inhibits the binding of PPAR/R
XR alpha heterodimers and of other nuclear hormone receptors, to perox
isome proliferator-responsive DNA elements in vitro. However, overexpr
ession of calreticulin in transiently transfected cultured cells had l
ittle or no effect on transactivation mediated by PPAR/RXR alpha. Ther
efore, while calreticulin inhibits the binding of both nuclear and ste
roid hormone receptors to cognate response elements in vitro, our find
ings suggest that calreticulin does not necessarily play an important
role in the regulation of all classes of hormone receptors in vivo.